Recombinant interferon alfa-2C versus polychemotherapy (VMCP) for treatment of multiple myeloma: a prospective randomized trialHeinz Ludwig, R. Flener, R. Kuzmits et al.|European Journal of Cancer and Clinical Oncology|1986Cited by 44
Treatment with Recombinant Interferon-Alpha-2C: Multiple Myeloma and Thrombocythaemia in Myeloproliferative DiseasesHeinz Ludwig, R. Flener, Agostino Cortelezzi et al.|Oncology|2009Cited by 22
Phase II Results with Recombinant Interferons: Renal Cell Carcinoma and Malignant MelanomaR. Kuzmits, R. Flener, E. M. Kokoschka et al.|Oncology|2009Cited by 20
[Interferon in the treatment of multiple myeloma].R. Kuzmits, Werner Scheithauer, H. Ludwig et al.|PubMed|1985Cited by 3
[Interferon (IFN) therapy (recombinant IFN-alpha-2C or recombinant IFN-gamma) in metastasized hypernephroma].R. Kuzmits, R. Flener, Werner Scheithauer et al.|PubMed|1985Cited by 2